The factors in favour of a rise in the Novartis share price:
First of all, of course, the international dimension of the company is a strength. The Novartis Group has pharmaceutical operations in no fewer than 140 countries around the world, protecting it from potential risks associated with a single geographic region.
It should also be noted that the core business of Novartis is in a sector which is particularly valued for its very broad market, namely pharmaceuticals. However, the Group has diversified its products within this sector with medical products as well as vaccines, consumer health products, generic pharmaceuticals and animal health and veterinary care products. In this way, it is multiplying its targets and areas of intervention.
Thanks to the Novartis Biotechnology subsidiary, the Novartis group is a true leader in its field of activity, conducting a great deal of research in order to develop increasingly effective treatments. Of course, the group protects its most innovative products by means of patents in order to be the only one to be able to exploit them.
Novartis also tends to develop its activities through a very important policy of mergers and acquisitions. Novartis regularly acquires companies specializing in various fields, thereby strengthening its brand and expanding the scope of its activities.
The group also enjoys a good brand image with the general public thanks to various initiatives that have been hailed by critics. These include corporate wellness, which was the group's first specialized health initiative, but also its commitment to the Convention on Biological Diversity, or CBD, which guarantees continued access to biological resources in developing countries for research and development purposes.
It is also worth noting that Novartis is a company that is valued by its customers, having been named one of the world's most respected companies in 2005, which continues to give Novartis a high level of trust from its major customers.
Finally, the final advantage of the Novartis Group is, of course, its workforce. Today, the company employs more than 120,000 people around the world who help develop new products and bring them to market.